Compare Letrazole and Anastrazole for SOB/lung/breathing problems.

Letrozole vs. Anastrozole: Respiratory Side Effects

I appreciate your question about these two aromatase inhibitors (AIs). However, I need to be direct with you: the webinar resources I have access to don't contain specific comparative data on letrozole versus anastrozole regarding shortness of breath (SOB) or lung/breathing problems.

What I Can Tell You Educationally:

Both letrozole and anastrozole are aromatase inhibitors — drugs that block estrogen production and are commonly used to treat hormone receptor-positive (ER+) breast cancer. They work through similar mechanisms, but they do have some pharmacological differences.

General respiratory considerations with AIs:

• Shortness of breath and lung issues are not listed as primary or common side effects of either drug in standard oncology references
• However, any new or worsening breathing problems during cancer treatment should be evaluated by your healthcare team, as they could indicate:
  • Cardiac effects (some AIs can affect heart function)
  • Pulmonary complications unrelated to the drug
  • Other treatment-related issues

Questions to Ask Your Oncologist:

1. "I'm experiencing shortness of breath. Could this be related to letrozole/anastrozole, or should we investigate other causes?"
2. "Are there differences in how these two drugs affect lung function or cardiac health?"
3. "Would switching between these AIs be appropriate given my symptoms?"
4. "Should I have cardiac or pulmonary testing to rule out other causes?"
5. "Are there alternative endocrine therapies I should consider if breathing problems persist?"

Important Note:

If you're experiencing new or worsening shortness of breath, contact your oncology team promptly — this warrants evaluation regardless of which AI you're taking.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.